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The aim of this review is to analyse anaesthesiologic preoperative assessment, intraoperative manage-
ment and postoperative complications of patients with thyroid disease. A special care is paid to difﬁcult
airway recognition and resolving this situation. Anaesthetist’s and surgeon’s point of view of perioper-
ative and postoperative complications is both discussed with special interest on early surgical compli-
cations and the need for urgent anaesthetic treatment. Particularly total intravenous anaesthesia and
recurrent laryngeal nerve monitoring actually are two end-points in the thyroid surgery.
 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Thyroid diseases which have anaesthetic implications include
hypothyroidism, hyperthyroidism and conditions requiring
thyroidectomy. Anaesthesia for thyroidectomy may be complicated
by airway problems such as retrosternal extension of the gland. The
anaesthetist should therefore pay particular care to preoperative
airways’ assessment and should be able to deal with acute airway
complications in the perioperative phase.
2. Preoperative assessment
Identiﬁcation of abnormalities of thyroid function is dued to
schedule patients: symptoms and signs of hypo- and hyperthy-
roidism and evidences of other medical conditions should be
sought, particularly cardiorespiratory diseases and associated
endocrine disorders. Routine investigations include thyroid func-
tion tests, haemoglobin, white cell and platelet count, urea and
electrolytes, including serum calcium, chest X-ray and indirect
laryngoscopy in order to document any preoperative vocal cord
dysfunction.1 Seeking for some evidence of tracheal compression
and deviation a lateral thoracic X-ray is requested instead the only
antero-posterior one to show tracheal compression. Other non-
routinary investigations are useful to value certain cases: compu-
terised tomography (CT) can provide excellent views of retrosternal
goitres2 and magnetic resonance imaging (MRI) has the advantage: þ39 0332278581.
. Bacuzzi).
ciates Ltd. Published by Elsevier Ltto provide images in the sagittal and coronal planes as well as
transverse views3 (Figs. 1 and 2). Preoperative airway evaluation
using new multislice 3D CT and high-resolution virtual laryngos-
copy based on spiral CT data for patients with severe tracheal
stenosis is useful. 3D ﬁgures of the trachea and a virtual broncho-
scopic movie can be obtained from multislice CT scanning to
evaluate the stenotic region and to simulate the virtual movie
ﬁbroscopic tracheal intubations. Anaesthesia’s choice will be
modulated by therecoming’s data.
2.1. Retrosternal goitre
Although some retrosternal goitres are large the vast majority
can be removed by the cervical route.4 The surgeon’s manipulation
worsens the retrosternal gland by compressing the trachea. Thyroid
surgery also occasionally requires mediastinal exploration so that it
should be better the endocrine theatre team to perform a sternot-
omy. Longstanding goitre may perform tracheal deviation and
compression which suggest tracheomalacia. Anaesthesia for ret-
rosternal goitre provides a challenge to the anaesthetist during
establishment of airway and the incidence of complications can be
greatly reduced by adequate preoperative assessment and
planning.
3. Thyroid disease and anaesthetic implication
3.1. Hyperthyroidism
Hyperthyroidism results from excessive tissue and circulating
concentrations of thyroid hormones. Clinical manifestationsd. All rights reserved.
Fig. 1. Coronal MRI scan of anaplastic thyroid cancer.
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although measured catecholamine levels are within normal limits.
3.1.1. Perioperative considerations
- Determine if hyperthyroidism is under control looking for signs
and symptoms of a hypermetabolic state, reviewing thyroid
function tests, other pertinent studies, medications and treat-
ment’s duration. Propylthiouracil and methimazole are the
preferred drugs for preoperative preparation but it takes weeks
to render a patient euthyroid. Iodine is often added to thio-
namide treatment. Beta-blockers reduce heart rate and provide
symptomatic relief as well as cardiac protection but do not
affect thyroxine production or iodine metabolism and do not
prevent thyroid storm.Fig. 2. Axial MRI scan of anaplastic thyroid cancer.- Only emergent procedures preclude waiting for a euthyroid
state! Rapid preparation may be required: administer
a combination of beta-blocker, corticosteroid, thionamide,
iodine, and iopanoic acid.
- Be aware that overzealous beta-blockade could precipitate
congestive heart failure, bronchospasm and hypoglycaemia in
diabetics. Consider corticosteroids because adrenal reserves
may be low. A strict monitoring is dued to evidence cardio-
vascular impairment.
3.2. Hypothyroidism
Hypothyroidism may results in depression of myocardial func-
tion, decreased spontaneous ventilation, abnormal baroreceptor
function, reduced plasma volume, anaemia, hypoglycaemia, hypo-
natraemia and impaired hepatic drug metabolism.
3.2.1. Perioperative considerations
- The combination of intravenous T3 and T4 is recommended for
preoperative myxoedematous coma management to make the
patient euthyroid.
- If possible avoid premedication and use regional anaesthesia.
T4 may be omitted in the morning of surgery but it is advisable
to give the patient’s usual morning dose of T3.
- Preventive measures should be adopted to protect against
hypothermia. Hypothyroid patients should receive hydrocor-
tisone cover during increasing surgical stress.5
3.3. Thyroid crisis
Thyroid crisis still occurs in uncontrolled hyperthyroid patients
as a result of a trigger such as surgery, infection or trauma.
Supportive management includes hydration, cooling, inotropes and
formerly steroids. Beta-blockade by labetalol or esmolol and anti-
thyroid drugs is the ﬁrst-line treatment. An acute thyroid crisis at
induction of anaesthesia, which was mistakenly diagnosed as
malignant hyperthermia, was successfully treated by boluses of
dantrolene 1 mg kg1. Thyroid hormones sensitise the adrenergic
receptors to endogenous catecholamines therefore magnesium
sulphate seems to be a useful drug by reducing the incidence and
severity of dysrhythmias caused by catecholamines.6
4. Anaesthetic technique
4.1. Regional anaesthesia
It is possible to perform thyroidectomy under bilateral deep
and/or superﬁcial cervical plexus blocks.7 Our opinion with bilat-
eral deep cervical plexus block suggests that it is a dangerous
technique concerning to its serious complications. Regional (local)
anaesthesia is a useful alternative for particular circumstances, e.g.
video-assisted thyroidectomy (VAT) performed under superﬁcial
cervical plexus block (mono or bilateral). Cervical epidural anaes-
thesia is another technique particularly useful if respiratory prob-
lems. Close monitoring of haemodynamics, respiratory rate and
level blockade is required.8
4.2. General anaesthesia
General anaesthesia with tracheal intubation and muscle
relaxation is the most popular anaesthetic technique for
thyroidectomy. It is wise to select a small-reinforced tracheal tube
if there is some degree of tracheal compression. Intravenous
anaesthesia and total intravenous anaesthesia (TIVA) become
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Several intravenous hypnotics and analgesics are currently used
for the induction and maintenance of general anaesthesia: pro-
pofol and alfentanil have the most suitable pharmacokinetic and
pharmacodynamic proﬁles for administration by continuous
infusion. Propofol is the best suited intravenous agent for main-
tenance of anaesthesia, as it provides a rapid onset of anaesthesia,
as shown by its short equilibration half-times (T1/2 Ke0) and rapid
recovery, as shown by its short context-sensitive half-times. In
addition propofol has several advantages over volatile anaes-
thetics such as a very low incidence of postoperative nausea and
vomiting and it could be safely used in patients susceptible to
malignant hyperthermia. Propofol and opioids in general as well
as propofol and alfentanil potentiate one another when given
perioperatively. A similar behaviour in drug interaction can be
seen when propofol is combined with remifentanil, the youngest
opioid, which is characterised – in contrast to alfentanil –
by an extremely short duration of action and which allows
furthermore a rapid and predictable response to alterations in
dose.9,105. Difﬁcult tracheal intubation in thyroid surgery
The anaesthetist should expect that 6% of tracheal intubations
for thyroid surgery will be difﬁcult. The evaluation of factors
linked to difﬁcult endotracheal intubation (DEI) is limited to
a few studies. In the study of Bouaggad11 with multivariate
analysis, two criteria were recognised as independent for DEI
(Cormack Grade III or IV and cancerous goitre) and it concludes
that a large goitre is not associated with a more frequent DEI.
However, the presence of a cancerous goitre is a major factor
predicting DEI caused by tracheal invasion and tissue inﬁltration
by the carcinoma associated with ﬁbrosis which may reduce the
mobility of laryngeal structures and make the laryngoscopic view
more difﬁcult. Whenever supposing that the airway will be lost if
anaesthesia is induced, awake ﬁbreoptic intubation is the method
of choice.6. Intraoperative neuromonitoring
The incidence of temporary unilateral vocal cord paralysis
resulting from damage to the recurrent laryngeal nerve (RLN) is
3–4%. Permanent unilateral vocal cord paralysis occurs in <1% of
patients and bilateral vocal cord paralysis should be extremely
rare. Injury to the recurrent laryngeal nerve may occur by several
mechanisms including ischaemia, contusion, traction, entrapment
and actual transection. There is a greater risk of nerve damage
during surgery for malignancy and reintervention. Attempts to
protect the recurrent laryngeal nerve during thyroidectomy
involve detecting vocal cord movement after nerve’s stimulation.
Intraoperative electro-physiological monitoring concerns the use
of a tracheal tube with integrated EMG electrodes positioned at
the level of the vocal cords. When the RLN has been identiﬁed,
the nerve is stimulated until an evoked EMG is obtained. In
addition to the atraumatic dissection of the RLN, intraoperative
neuromonitoring has become accepted practice during surgery in
this area.
A quantitative neurophysiological evaluation of the RLN is based
on the recording of evoked potential at the vocalis muscle. Thus
neuromuscular blockade may interfere with intraoperative neuro-
monitoring of the RLN. In the study of Marush et al. the inﬂuence of
muscle relaxation on neuromonitoring of the recurrent laryngeal
nerve was investigated. The main ﬁndings were that neuro-
monitoring of the RLN is applicable despitemuscle relaxation<90%and that the laryngeal muscles exhibited a shorter response time
than the adductor pollicis and quickly recovered.12
7. Postoperative complications
7.1. Haematoma
Postoperative haemorrhage is potentially catastrophic when
someone is operating on the neck but it could be avoided by fair
haemostasis. The anaesthetist may be asked to maintain the
patient’s intrathoracic pressure positive for 10–20 s in order to
assess haemostasis before wound closure.13 Clip removers usually
were kept at the bedside to enable rapid relief of a haematoma. Fast
decision-making is important and early re-intubation is recom-
mended. The later intubation is obviously performed the more
difﬁcult it becomes as the haematoma expands and compresses the
airway.
Respiratory obstruction may be caused by laryngeal and
pharyngeal oedema as a result of venous and lymphatic obstruction
by the haematoma rather than direct tracheal compression.
7.2. Tracheomalacia
Tracheal collapse following thyroidectomy results from pro-
longed compression of the trachea by a large, neglected goitre,
particularly within the conﬁnes of the thoracic inlet.14 It is a life-
threatening complication,15 which should be considered before
extubation, and management strategies should be available.
Management of tracheomalacia requires urgent re-intubation,
possibly tracheostomy and some forms of tracheal support such
as ceramic rings.
7.3. Laryngeal oedema
Laryngeal complications of tracheal intubation can be seen
during the postoperative indirect laryngoscopy which is performed
to identify recurrent laryngeal nerve damage. Oedema and trau-
matic lesions were noted in 4.6% of patients.16 While trauma to the
larynx from the tracheal tube will cause minor swelling, laryngeal
oedema is a rare cause of post-thyroidectomy respiratory
obstruction.
7.4. Hypocalcaemia
After thyroidectomy for large multinodular goitre the incidence
of temporary hypocalcaemia occurs in 20% of patients about 36 h
postoperatively. This might be reduced by more careful inspection
of the thyroid capsule.17
7.5. Postoperative nausea and vomiting
Patients undergoing thyroidectomy are at high risk for the
development of postoperative nausea and vomiting (PONV).
Combination antiemetic therapy with granisetron plus droperidol
or granisetron plus dexamethasone is highly effective in preventing
PONV.18
7.6. Postoperative pain
Patients usually tolerate thyroidectomy very well and require
minimal postoperative analgesia. They often complain of a stiff
neck because of the position during surgery rather than pain
from the site of the incision. Concerning these considerations it
is successful to combine NSAIDs and acetaminophene. We
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operative pain protocols to be started within the intervention.8. Conclusion
Anaesthesia for thyroid surgery requires an anaesthetist who
is experienced in the recognition, assessment and management of
a potentially difﬁcult, shared airway, in a patient who may also
have signiﬁcant co-morbidity. We believe that TIVA is the ﬁrst
choice technique for thyroid surgery in order of its fast and gentle
recovery from anaesthesia and concerning the lower incidence of
postoperative nausea and vomiting. Neuromonitoring during
thyroidectomy is effective in providing identiﬁcation and function
of laryngeal nerves. The anaesthetist is strictly involved in this
technique being responsible of the right positioning of the
endotracheal tube and the management of the neuromuscular
blockade.Conﬂict of interest
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